Respiratory Disease

Respiratory
1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

GSK
GSKLONDON, United Kingdom
1 program
1
AIO-001Phase 11 trial
Active Trials
NCT06170827Completed16Est. Jul 2024
Senti Biosciences
Senti BiosciencesCA - South SF
1 program
Senti V1.0 DeviceN/A1 trial
Active Trials
NCT04693091UnknownEst. Apr 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GSKAIO-001
Senti BiosciencesSenti V1.0 Device

Clinical Trials (2)

Total enrollment: 16 patients across 2 trials

Study to Evaluate the AIO-001 in Healthy Participants

Start: Nov 2023Est. completion: Jul 202416 patients
Phase 1Completed

Feasibility of Remote Evaluation and Monitoring of Acoustic Pathophysiological Signals With External Sensor Technology

Start: Feb 2021Est. completion: Apr 2021
N/AUnknown

Related Jobs in Respiratory

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space